Michael C. Mithoefer

5.5k total citations · 1 hit paper
29 papers, 2.1k citations indexed

About

Michael C. Mithoefer is a scholar working on Clinical Psychology, Pharmacology and Cognitive Neuroscience. According to data from OpenAlex, Michael C. Mithoefer has authored 29 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Clinical Psychology, 20 papers in Pharmacology and 5 papers in Cognitive Neuroscience. Recurrent topics in Michael C. Mithoefer's work include Psychedelics and Drug Studies (25 papers), Cannabis and Cannabinoid Research (19 papers) and Treatment of Major Depression (5 papers). Michael C. Mithoefer is often cited by papers focused on Psychedelics and Drug Studies (25 papers), Cannabis and Cannabinoid Research (19 papers) and Treatment of Major Depression (5 papers). Michael C. Mithoefer collaborates with scholars based in United States, Canada and Netherlands. Michael C. Mithoefer's co-authors include Rick Doblin, Lisa Jerome, Ann T. Mithoefer, Mark T. Wagner, Allison A. Feduccia, Berra Yazar‐Klosinski, Timothy D. Brewerton, Amy Emerson, Charles S. Grob and Scott Hamilton and has published in prestigious journals such as PLoS ONE, Scientific Reports and Psychopharmacology.

In The Last Decade

Michael C. Mithoefer

27 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial

2018 272 citations Michael C. Mithoefer, Ann T. Mithoefer et al. The Lancet Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael C. Mithoefer United States	18	1.9k	812	682	607	397	29	2.1k
Lisa Jerome United States	19	1.8k 1.0×	808 1.0×	688 1.0×	583 1.0×	463 1.2×	25	2.1k
Berra Yazar‐Klosinski United States	18	1.9k 1.0×	913 1.1×	591 0.9×	808 1.3×	319 0.8×	28	2.2k
Rick Doblin United States	22	2.4k 1.3×	1.1k 1.4×	845 1.2×	921 1.5×	469 1.2×	36	2.8k
Torsten Passie Germany	24	2.1k 1.1×	1.1k 1.3×	470 0.7×	1.1k 1.8×	297 0.7×	50	2.7k
Yasmin Schmid Switzerland	27	2.1k 1.1×	1.2k 1.5×	446 0.7×	846 1.4×	472 1.2×	57	2.7k
John H. Halpern United States	23	1.3k 0.7×	814 1.0×	453 0.7×	674 1.1×	367 0.9×	38	2.3k
José Carlos Bouso Spain	32	2.8k 1.5×	1.1k 1.4×	749 1.1×	1.1k 1.7×	273 0.7×	114	3.2k
Valerie H. Curran United Kingdom	10	1.1k 0.6×	765 0.9×	639 0.9×	600 1.0×	179 0.5×	15	1.9k
Natasha L. Mason Netherlands	26	1.8k 1.0×	977 1.2×	343 0.5×	1.0k 1.7×	209 0.5×	73	2.2k
Patrick C. Dolder Switzerland	27	2.0k 1.1×	1.3k 1.5×	189 0.3×	1.1k 1.8×	306 0.8×	43	2.5k

Countries citing papers authored by Michael C. Mithoefer

Since Specialization

Citations

This map shows the geographic impact of Michael C. Mithoefer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael C. Mithoefer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael C. Mithoefer more than expected).

Fields of papers citing papers by Michael C. Mithoefer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael C. Mithoefer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael C. Mithoefer. The network helps show where Michael C. Mithoefer may publish in the future.

Co-authorship network of co-authors of Michael C. Mithoefer

This figure shows the co-authorship network connecting the top 25 collaborators of Michael C. Mithoefer. A scholar is included among the top collaborators of Michael C. Mithoefer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael C. Mithoefer. Michael C. Mithoefer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Julie B., Rachel Yehuda, Allison R. Coker, et al.. (2024). Effects of MDMA-assisted therapy for PTSD on self-experience. PLoS ONE. 19(1). e0295926–e0295926. 14 indexed citations

O’Donnell, Kelley C., Christopher R. Nicholas, Chantelle Thomas, et al.. (2024). The conceptual framework for the therapeutic approach used in phase 3 trials of MDMA-assisted therapy for PTSD. Frontiers in Psychology. 15. 11 indexed citations

Singleton, S. Parker, Julie B. Wang, Michael C. Mithoefer, et al.. (2023). Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder. Frontiers in Psychiatry. 13. 947622–947622. 21 indexed citations

Marseille, Elliot, Christopher S. Stauffer, Manish Agrawal, et al.. (2023). Group psychedelic therapy: empirical estimates of cost-savings and improved access. Frontiers in Psychiatry. 14. 1293243–1293243. 10 indexed citations

Brewerton, Timothy D., Julie B. Wang, Adèle Lafrance, et al.. (2022). MDMA-assisted therapy significantly reduces eating disorder symptoms in a randomized placebo-controlled trial of adults with severe PTSD. Journal of Psychiatric Research. 149. 128–135. 40 indexed citations

Wang, Julie B., Jessica Lin, Allison R. Coker, et al.. (2021). Scaling Up: Multisite Open-Label Clinical Trials of MDMA-Assisted Therapy for Severe Posttraumatic Stress Disorder. Journal of Humanistic Psychology. 14 indexed citations

Wagner, Anne Catherine, Rachel E. Liebman, Ann T. Mithoefer, Michael C. Mithoefer, & Candice M. Monson. (2021). Relational and Growth Outcomes Following Couples Therapy With MDMA for PTSD. Frontiers in Psychiatry. 12. 702838–702838. 22 indexed citations

Jerome, Lisa, et al.. (2021). Sleep Quality Improvements After MDMA‐Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder. Journal of Traumatic Stress. 34(4). 851–863. 33 indexed citations

Feduccia, Allison A., Lisa Jerome, Julie B. Wang, et al.. (2020). MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study. Scientific Reports. 10(1). 20442–20442. 88 indexed citations

10.

Brewerton, Timothy D., Adèle Lafrance, & Michael C. Mithoefer. (2020). The potential use of N-methyl-3,4-methylenedioxyamphetamine (MDMA) assisted psychotherapy in the treatment of eating disorders comorbid with PTSD. Medical Hypotheses. 146. 110367–110367. 19 indexed citations

11.

Feduccia, Allison A., Lisa Jerome, Berra Yazar‐Klosinski, et al.. (2019). Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline. Frontiers in Psychiatry. 10. 650–650. 108 indexed citations

12.

Wagner, Anne Catherine, Michael C. Mithoefer, Ann T. Mithoefer, & Candice M. Monson. (2019). Combining Cognitive-Behavioral Conjoint Therapy for PTSD with 3,4-Methylenedioxymethamphetamine (MDMA): A Case Example. Journal of Psychoactive Drugs. 51(2). 166–173. 29 indexed citations

13.

Mithoefer, Michael C., Ann T. Mithoefer, Allison A. Feduccia, et al.. (2018). 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. The Lancet Psychiatry. 5(6). 486–497. 272 indexed citations breakdown →

14.

Feduccia, Allison A. & Michael C. Mithoefer. (2018). MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 84(Pt A). 221–228. 140 indexed citations

15.

G., Marcela Ot’alora, Jim Grigsby, Lisa Jerome, et al.. (2018). 3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial. Journal of Psychopharmacology. 32(12). 1295–1307. 155 indexed citations

16.

Feduccia, Allison A., Julie Holland, & Michael C. Mithoefer. (2017). Progress and promise for the MDMA drug development program. Psychopharmacology. 235(2). 561–571. 44 indexed citations

17.

Wagner, Mark T., Michael C. Mithoefer, Ann T. Mithoefer, et al.. (2017). Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy. Journal of Psychopharmacology. 31(8). 967–974. 89 indexed citations

18.

Mithoefer, Michael C., Charles S. Grob, & Timothy D. Brewerton. (2016). Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA. The Lancet Psychiatry. 3(5). 481–488. 181 indexed citations

19.

Mithoefer, Michael C., Mark T. Wagner, Ann T. Mithoefer, Lisa Jerome, & Rick Doblin. (2010). The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. Journal of Psychopharmacology. 25(4). 439–452. 446 indexed citations

20.

Mithoefer, Michael C.. (2007). S.26.02 MDMA facilitated treatment of PTSD. European Neuropsychopharmacology. 17. S216–S216.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact